Maria Tresini

Maria Tresini

Auto-generated profile, based on publicly available information

Maria Tresini

Center for Gerontological Research, Allegheny University, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2000 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
RAR.G Allen
R.G Allen
MTMaria Tresini
Maria Tresini

24 June 2015 in Nature
Verified
Journal Article
Open access
PDF file
MTMaria Tresini
Maria Tresini
DWDaniël O. Warmerdam
Daniël O. Warmerdam
PKPetros Kolovos
Petros Kolovos
LSLoes Snijder
Loes Snijder
MVMischa G. Vrouwe
Mischa G. Vrouwe
JMJurgen A. Marteijn
Jurgen A. Marteijn
In response to DNA damage, tissue homoeostasis is ensured by protein networks promoting DNA repair, cell cycle arrest or apoptosis. DNA damage response signalling pathways coordinate these processes, partly by propagating gene-expression-modulating signals. DNA damage influences not only the abundance of messenger RNAs, but also their coding information through alternative splicing. Here we show that transcription-blocking DNA lesions promote chromatin displacement of late-stage spliceosomes and initiate a positive feedback loop centred on the signalling kinase ATM. We propose that initial spliceosome displacement and subsequent R-loop formation is triggered by pausing of RNA polymerase at DNA lesions. In turn, R-loops activate ATM, which signals to impede spliceosome organization further and augment ultraviolet-irradiation-triggered alternative splicing at the genome-wide level. Our findings define R-loop-dependent ATM activation by transcription-blocking lesions as an important event in the DNA damage response of non-replicating cells, and highlight a key role for spliceosome displacement in this process.

1 October 2004 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
VCVincent J. Cristofalo
Vincent J. Cristofalo
Antonello LorenziniAntonello Lorenzini
Antonello Lorenzini
RAR.G. Allen
R.G. Allen
CTClaudio Torres
Claudio Torres
MTMaria Tresini
Maria Tresini

14 March 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YPYuri Pekarsky
Yuri Pekarsky
AKAnatoliy Koval
Anatoliy Koval
CHCora Hallas
Cora Hallas
RBRoberta Bichi
Roberta Bichi
MTMaria Tresini
Maria Tresini
CCCarlo M. Croce
Carlo M. Croce
The TCL1 oncogene at 14q32.1 is involved in the development of human mature T-cell leukemia. The mechanism of action of Tcl1 is unknown. Because the virus containing the v-akt oncogene causes T-cell lymphoma in mice and Akt is a key player in transduction of antiapoptotic and proliferative signals in T-cells, we investigated whether Akt and Tcl1 function in the same pathway. Coimmunoprecipitation experiments showed that endogenous Akt1 and Tcl1 physically interact in the T-cell leukemia cell line SupT11; both proteins also interact when cotransfected into 293 cells. Using several AKT1 constructs in cotransfection experiments, we determined that this interaction occurs through the pleckstrin homology domain of the Akt1 protein. We further demonstrated that, in 293 cells transfected with TCL1, the endogenous Akt1 bound to Tcl1 is 5–10 times more active compared with Akt1 not bound to Tcl1. The intracellular localization of Tcl1 and Akt1 in mouse fibroblasts was investigated by immunofluorescence. When transfected alone, Akt1 was found only in cytoplasm whereas Tcl1 was localized in the cytoplasm and in the nucleus. Interestingly, Akt1 was also found in the nucleus when AKT1 was cotransfected with TCL1, suggesting that Tcl1 promotes the transport of Akt1 to the nucleus. These findings were supported by the intracellular localization of Akt1 or Tcl1 when Tcl1 or Akt1, respectively, were confined to the specific cellular compartments. Thus, we demonstrate that Tcl1 is a cofactor of Akt1 that enhances Akt1 kinase activity and promotes its nuclear transport.

1 August 2013 in Molecular Cell
Verified
Journal Article
Closed access
CDChristoffel Dinant
Christoffel Dinant
GAGiannis Ampatziadis-Michailidis
Giannis Ampatziadis-Michailidis
HLHannes Lans
Hannes Lans
MTMaria Tresini
Maria Tresini
ALAnna Lagarou
Anna Lagarou
JMJurgen A. Marteijn
Jurgen A. Marteijn

1 January 1998 in Critical Reviews™ in Eukaryotic Gene Expression
Verified
Journal Article
Closed access
VCVincent J. Cristofalo
Vincent J. Cristofalo
CVCraig Volker
Craig Volker
MFMary Kay Francis
Mary Kay Francis
MTMaria Tresini
Maria Tresini
Normal human fibroblasts exhibit a limited proliferative potential in culture. When populations are serially subcultured, they grow well initially, but ultimately reach a stage when they are no longer able to proliferate in response to mitogenic stimuli. This state is designated "replicative senescence". In addition to failure to proliferate, numerous morphological and physiological changes characterize the senescent phenotype. Both stochastic and genetic mechanisms have been postulated as causal effectors of the aging process. However, the pathway leading to cellular senescence is likely to be complex with numerous changes. In this article we provide an overview of cell and molecular changes that occur during cell aging, with special emphasis on signal transduction pathways and cell cycle proteins that are likely to play key roles in determining the limited replicative life span and the changes that occur.